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Editorial on the Research Topic
Cellular and Molecular Mechanisms of Neurotrophin Function in the Nervous System
The discovery of nerve growth factor (NGF) by Rita Levi-Montalcini in the 1950s represents
an important milestone in the processes that led to modern cell biology (Aloe, 2004). NGF
is a member of the neurotrophin family. Neurotrophins are a family of proteins that regulate
development, maintenance, and function of vertebrate nervous systems. They serve as survival
factors to ensure a match between the number of surviving neurons and the requirement
for appropriate target innervation and also regulate cell fate decisions, axon growth, dendrite
pruning, the patterning of innervation and the expression of proteins crucial for normal neuronal
function, such as neurotransmitters and ion channels. They signal through specific tyrosine kinase
receptor (trkA, trkB, trkC) and the low affinity receptor p75NTR. Moreover, the precursors of the
neurotrophins (“pro-neurotrophins”) are discussed to be biologically active by signaling through
specific receptors. Brain-derived neurotrophic factor (BDNF), NGF and the neurotrophins 3 and
4 (NT3, NT4) as well as their precursors (pro-neurotrophins) are not only expressed during
development, but also in the postnatal brain.
Neurotrophins also have important functions in themature nervous system. In particular, BDNF
is involved in learning and memory and in neuronal plasticity. Changes in BDNF expression
especially in the hippocampal formation are associated, among others, with psychiatric disease.
BDNF levels are reduced in postmortem brain samples and in the blood of depressed patients, and
these reductions are reversible by successful antidepressant treatment (Castren and Rantamaki,
2008). Moreover, in humans, the BDNF val66met polymorphism might represent a biological
signature for the neuroanatomical and cognitive abnormalities commonly observed in patients
suffering from bipolar disorders (Cao et al., 2016). Moreover, recent data indicate that BDNF
concentrations were significantly lower in patients with attempted suicide/ideation and that
therefore BDNF concentrations could serve as a response marker for antidepressant treatment in
major depressive disorder (Ai et al., 2019).
Interventions like exercise or antidepressant treatment can enhance the expression of BDNF in
the brain. In the review article by Miranda et al. the role of BDNF as a key molecule for memory
processes in the healthy and the pathological brain is reviewed. While the role of BDNF in synaptic
plasticity and in memory formation is well-known, its participation in memory reconsolidation
has been less studied. In the Mini-review by Gonzalez et al. the involvement of BDNF signaling in
memory reconsolidation is discussed.
The hippocampus is a key structure for spatial and declarative memory formation. Most of our
knowledge on synaptic plasticity in mammals comes from hippocampal circuits, including the
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famous paradigm of long-term potentiation (von Bohlen und
Halbach et al., 2018). Moreover, adult hippocampal neurogenesis
is thought to be related to learning and memory functions.
Interestingly, neurotrophins are involved in hippocampal long-
term potentiation as well as in adult neurogenesis implicating an
important role in neuronal plasticity (von Bohlen und Halbach
and von Bohlen und Halbach, 2018). The Mini-review by
De Vincenti et al. focuses on mechanisms that modulate and
diversify BDNF functions and its implications for hippocampal
synaptic plasticity, thereby shedding light to novel mechanisms
that are discussed for the rapid, localized, and dynamic control
of BDNF release and function. In addition to that Mini-review,
the original article by Foltran et al. analyzes the differential
hippocampal expression of BDNF isoforms and their receptors
under diverse configurations of the serotonergic system in a
mice model of increased neuronal survival. This work sheds
light on the role of the different BDNF isoforms in the
regulation of neurogenic process taking place in the murine
hippocampal formation.
Activation of the low affinity receptor p75NTR is known
to trigger synapse loss and neuronal death. These pathological
features are also caused by the human immunodeficiency virus-
1 (HIV) envelope protein gp120, which increases the levels of
proBDNF. The research article by Speidell et al. portrays the
interaction of p75NTR with the human immunodeficiency virus-
1 (HIV) envelope protein gp120 in the brain and suggests that
activation of p75NTR is one of the mechanisms crucial for the
neurotoxic effect of gp120. Furthermore, the research article
by Zhang et al. focuses on the involvement BDNF and NGF
in peripheral nerve injury and indicates that increased levels
of BDNF and NGF are associated with promoted sciatic nerve
regeneration and improved nerve function.
Aside from the neurotrophins further substances have
neurotrophic properties. Among them is the well-known family
of fibroblast growth factors as well as the insulin like growth
factors. The article by Chen W. et al. highlights the capacity of
insulin-like growth factor-1, derived from astrocytes, to protect
neurons against excitotoxicity. Recently, it has been described
that interleukin 1 also plays a role in the nervous system and
the article by Chen G. et al. entitled “Interleukin-1β promotes
Schwann cells de-differentiation in Wallerian degeneration via
the c-JUN/AP-1 pathway” indicates that interleukin 1ß plays an
important role in Wallerian degeneration that is associated with
alterations in p75NTR expression.
Together, the series of articles, should give a brief overview
on the roles and function of neurotrophic substances in the
nervous system. Since one of the best-analyzed systems in this
context are represented by the neurotrophins and especially by
BDNF. Thus, the mini reviews mainly focus on the actions of
BDNF. However, since other factors also have been found to
have neurotrophic properties or interact with the neurotrophin
system, specific original articles were also included in the “Special
Issue.” We hope that this selection of articles will be helpful to get
insight in the fascinating world of the neurotrophins and their
actions in the central nervous system.
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